Argentina’s MoH to replenish health plans’ April losses



Argentina’s Ministry of Health (MoH) this week decided to throw a lifeline to health plans hit by the global economic downturn. The Superintendency of Health Services, which manages the health system's funds, will provide exceptional financial support to health plans whose revenues dropped in April this year compared to March, with the amount equal to the difference between the two months.

The move is aimed at ensuring the uninterrupted operation of these plans during the COVID-19 outbreak, as well as preventing default of payments to healthcare institutions.

Reference:

Related news
Carlos da Costa, an officer at Brazil’s Ministry of Economy (MoE), last week commented on the postponement in the allowed increase in drug prices for 2020, a measure that was announced in the end of March and is aimed at supporting patients during the COVID-19 outbreak.
Peru’s Ministry of Health (MINSA) last week declared dexamethasone, epinephrine, and methylprednisolone obligatory generics that must be available in all pharmacies in the country.
Medtronic plc (NYSE:MDT), which operates out of the US but has its tax base in Ireland, released its financial report for Q4 2020 (ended April 24), revealing the full impact of the COVID-19 outbreak.
Shanghai-based biotech Junshi Biosciences (HKEX: 1877) released preclinical research data on two COVID-19 neutralizing monoclonal antibodies (mAbs) in an article to Nature this week.
Chile’s Ministry of Health (MINSAL) this week donated 200,000 tablets of an unnamed tuberculosis treatment to Ecuador, whose programmed shipments have been delayed as a result of the COVID-19 pandemic on global supply chains.
Recent news
Colombia’s Financial Corporation for Territorial Development (FINDETER), a state-owned banking corporation, last week announced a COP 256 billion (USD 68 million) credit line for health plans and health institutions hit by the global economic downturn.
Hebei's provincial Healthcare Commission bureau released a notice setting out a broad range of medical reforms, linking together medical care, medical insurance, pharmaceuticals pricing, and in particular centralized drug procurement.
Carlos da Costa, an officer at Brazil’s Ministry of Economy (MoE), last week commented on the postponement in the allowed increase in drug prices for 2020, a measure that was announced in the end of March and is aimed at supporting patients during the COVID-19 outbreak.
China is ramping up appointment diagnosis and treatment systems and intelligent hospital infrastructure.
Argentine drug maker Elea-Phoenix has purchased two established products from Sanofi, continuing the French firm’s divestment of its over-the-counter (OTC) drugs and expanding on a previous deal between the two firms announced in March this year.
Wu Depei, CPPCC member and hematology department director at the First Affiliated Hospital of Soochow University, suggested immune thrombocytopenia (ITP) be included in medical insurance schemes.
China-based Lee’s Pharmaceutical Holdings Ltd (950.HK) released its Q1 2020 financial report, recording income down 3.5% year-on-year (YOY) to HKD 273 million (USD 35.2 million), and net profits down 15% YOY to HKD 39.9 million (USD 5.2 million). Sales for Lee’s Pharma surgery drugs hemocoagulase and low-molecular-weight heparin calcium decreased 34.8% and 33.1% respectively, as non-emergency surgeries were deprioritized by hospitals due to the COVID-19 pandemic.
Analytics Snapshot


Analytics Snapshot